The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update
Open accessAbstract
Codeine is bioactivated to morphine, a strong opioid agonist, by the hepatic cytochrome P450 2D6 (CYP2D6); hence, the efficacy and safety of codeine are governed by CYP2D6 activity. Polymorphisms are a major cause of CYP2D6 variability. We summarize evidence from the literature supporting this association and provide therapeutic recommendations for codeine based on CYP2D6 genotype. This document is an update to the 2012 Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2D6 genotype and codeine therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype
Gaedigk, A., Simon, S., Pearce, R., Bradford, L., Kennedy, M., & Leeder, J. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100406 · Cited by 779
Self-citationCodeine Intoxication Associated with Ultrarapid CYP2D6 Metabolism
Gasche, Y., Daali, Y., Fathi, M., Chiappe, A., Cottini, S., Dayer, P., & Desmeules, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041888 · Cited by 702
Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother
Koren, G., Cairns, J., Chitayat, D., Gaedigk, A., & Leeder, S. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69255-6 · Cited by 684
Self-citationJohansson, I., Lundqvist, E., Bertilsson, L., Dahl, M. L., Sjöqvist, F., & Ingelman-Sundberg, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11825 · Cited by 644
Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs
Volpe, D. A., Tobin, G. A. M., Mellon, R. D., Katki, A. G., Parker, R. J., Colatsky, T., Kropp, T. J., & Verbois, S. L. (2011) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2010.12.007 · Cited by 446
Kirchheiner, J., Schmidt, H., Tzvetkov, M., Keulen, J.-T., Lötsch, J., Roots, I., & Brockmöller, J. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500406 · Cited by 439
LALOVIC, B., KHARASCH, E., HOFFER, C., RISLER, L., LIUCHEN, L., & SHEN, D. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.01.009 · Cited by 413
Self-citationThe hypoalgesic effect of tramadol in relation to CYP2D6*
Poulsen, L., Arendt-Nielsen, L., Brøsen, K., & Sindrup, S. H. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90211-8 · Cited by 386
Crews, K. R., Gaedigk, A., Dunnenberger, H. M., Klein, T. E., Shen, D. D., Callaghan, J. T., Kharasch, E. D., & Skaar, T. C. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.287 · Cited by 371
Self-citationImpact of CYP2D6 genotype on postoperative tramadol analgesia
Stamer, U. M., Lehnen, K., Höthker, F., Bayerer, B., Wolf, S., Hoeft, A., & Stuber, F. (2003) · Pain · doi:10.1016/s0304-3959(03)00212-4 · Cited by 333
Abram, S. E. (2007) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/s1073-5437(08)70202-x · Cited by 318
Madadi, P., Ross, C., Hayden, M., Carleton, B., Gaedigk, A., Leeder, J., & Koren, G. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.157 · Cited by 308
Self-citationEckhardt, K., Li, S., Ammon, S., Schänzle, G., Mikus, G., & Eichelbaum, M. (1998) · Pain · doi:10.1016/s0304-3959(98)00021-9 · Cited by 258
Concentrations of Tramadol and O-desmethyltramadol Enantiomers in Different CYP2D6 Genotypes
Stamer, U. M., Musshoff, F., Kobilay, M., Madea, B., Hoeft, A., & Stuber, F. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100152 · Cited by 241
Samer, C., Daali, Y., Wagner, M., Hopfgartner, G., Eap, C., Rebsamen, M., Rossier, M., Hochstrasser, D., Dayer, P., & Desmeules, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00709.x · Cited by 201
Gaedigk, A., Gotschall, R. R., Forbes, N. S., Simon, S. D., Kearns, G. L., & Leeder, J. S. (1999) · Pharmacogenetics and Genomics · doi:10.1097/01213011-199912000-00002 · Cited by 181
Self-citationOntogeny of Dextromethorphan O- and N-demethylation in the First Year of Life
Blake, M. J., Gaedigk, A., Pearce, R. E., Bomgaars, L. R., Christensen, M. L., Stowe, C., James, L. P., Wilson, J. T., Kearns, G. L., & Leeder, J. S. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100101 · Cited by 169
Self-citationThe effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone
Samer, C., Daali, Y., Wagner, M., Hopfgartner, G., Eap, C., Rebsamen, M., Rossier, M., Hochstrasser, D., Dayer, P., & Desmeules, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00673.x · Cited by 166
Developmental Changes in Human Liver CYP2D6 Expression
Stevens, J. C., Marsh, S. A., Zaya, M. J., Regina, K. J., Divakaran, K., Le, M., & Hines, R. N. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021873 · Cited by 164
Apnea in a child after oral codeine: a genetic variant ? an ultra-rapid metabolizer
Voronov, P., Przybylo, H. J., & Jagannathan, N. (2007) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2006.02182.x · Cited by 156
Willmann, S., Edginton, A. N., Coboeken, K., Ahr, G., & Lippert, J. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.151 · Cited by 142
Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy
Davis, M. P., Varga, J., Dickerson, D., Walsh, D., LeGrand, S. B., & Lagman, R. L. (2003) · Supportive Care in Cancer · doi:10.1007/s00520-002-0385-9 · Cited by 121
Andreassen, T. N., Eftedal, I., Klepstad, P., Davies, A. N., Bjordal, K., Lundström, S., Kaasa, S., & Dale, O. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1093-5 · Cited by 116
Thorn, C. F., Klein, T. E., & Altman, R. B. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32832e0eac · Cited by 113
Self-citationPharmacogenetics of Analgesics: Toward the Individualization of Prescription
Rollason, V., Samer, C. F., Piguet, V., Dayer, P., & Desmeules, J. A. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.7.905 · Cited by 103
Kaplan, H. L., Busto, U. E., Baylon, G. J., Cheung, S. W., Otton, S. V., Somer, G. R., & Sellers, E. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36599-1 · Cited by 86
Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation?
Lötsch, J., Rohrbacher, M., Schmidt, H., Doehring, A., Brockmöller, J., & Geißlinger, G. (2009) · Pain · doi:10.1016/j.pain.2009.03.023 · Cited by 83
Allegaert, K., Rochette, A., & Veyckemans, F. (2010) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2010.03389.x · Cited by 67
CYP2D6 and The Severity of Suicide Attempts
Peñas‐Lledó, E., Blasco-Fontecilla, H., Dorado, P., Vaquero‐Lorenzo, C., Baca‐García, E., & LLerena, A. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.146 · Cited by 44
Kelly, L. E., Chaudhry, S. A., Rieder, M. J., Jong, G. W. ‘., Moretti, M. E., Lausman, A. Y., Ross, C. J., Berger, H. M., Carleton, B., Hayden, M. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070073 · Cited by 39
Genetic Variants of CYP2D6 Gene and Cancer Risk: A HuGE Systematic Review and Meta-analysis
Zhou, L., Luan, H., Dong, X.-H., Jin, G., Man, D., & Shang, H. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.7.3165 · Cited by 18
Cited by
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program
Taliun, D., Harris, D. N., Kessler, M. D., Carlson, J., Szpiech, Z. A., Torres, R., Taliun, S. A. G., Corvelo, A., Gogarten, S. M., Kang, H. M., et al. (2021) · Nature · doi:10.1038/s41586-021-03205-y · Cited by 2,213
Hicks, J., Bishop, Jr., Sangkuhl, K., Müller, D., Ji, Y., Leckband, S., Leeder, J., Graham, R., Chiulli, D., LLerena, A., et al. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.147 · Cited by 998
Self-citationPharmacogenomics in the clinic
Relling, M. V., & Evans, W. E. (2015) · Nature · doi:10.1038/nature15817 · Cited by 904
Caudle, K. E., Sangkuhl, K., Whirl‐Carrillo, M., Swen, J. J., Haidar, C. E., Klein, T. E., Gammal, R. S., Relling, M. V., Scott, S. A., Hertz, D. L., et al. (2020) · Clinical and Translational Science · doi:10.1111/cts.12692 · Cited by 536
Self-citationPreemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
Dunnenberger, H. M., Crews, K. R., Hoffman, J. M., Caudle, K. E., Broeckel, U., Howard, S. C., Hunkler, R. J., Klein, T. E., Evans, W. E., & Relling, M. V. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124835 · Cited by 511
Self-citation
Metadata
- Authors
- Crews, K. R., Gaedigk, A., Dunnenberger, H. M., Leeder, J. S., Klein, T. E., Caudle, K. E., Haidar, C. E., Shen, D. D., Callaghan, J. T., Sadhasivam, S., Prows, C. A., Kharasch, E. D., & Skaar, T. C.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2014-01-23
- Volume
- 95
- Issue
- 4
- Pages
- 376-382
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2091212941
- Cited by
- 680
- References
- 31
- FWCI
- 73.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.